Brief: PCI Biotech Holding Extends Preclinical Research Collaboration

PCI Biotech Holding ASA

18/01/2018 07:03

Jan 18 (Reuters) - PCI BIOTECH HOLDING ASA  PCIB.OL : 
    * EXTENDING PRECLINICAL RESEARCH COLLABORATION WITH 
UNDISCLOSED 
TOP-10 PHARMA COMPANY, INITIATED IN SEPTEMBER 2015 
    * WILL EVALUATE DATA GENERATED AND EXPLORE POTENTIAL FOR 
FURTHER 
PARTNERSHIP BASED ON OUTCOME 
    * -  EXTENDED EVALUATION PERIOD SPANS OVER 6 MONTHS, UNTIL 
THE END 
OF JUNE 2018, AND MAY BE FURTHER EXTENDED 
 
Source text for Eikon:  ID:nDJAR00109  
Further company coverage:  PCIB.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))